Jefferson Provost and Dean Mark Tykocinski Wins Prestigious Strittmatter Award

Mark Tykocinski, M.D., received the 2017 Strittmatter Award from the Philadelphia County Medical Society, its most prestigious scientific award.

Mark Tykocinski, M.D., received the 2017 Strittmatter Award from the Philadelphia County Medical Society, its most prestigious scientific award.

Mark Tykocinski, M.D., has been named the recipient of the 2017 Strittmatter Award from the Philadelphia County Medical Society (PCMS). The Society’s most prestigious scientific award honors a PCMS physician who has demonstrated valuable contributions to the healing art–surgical or medical. The award has been given since 1923 and is named for the 1881 Jefferson graduate Dr. Isidor Strittmater. Previous winners include noted physicians John Gibbon, who developed the first successful heart-lung machine; Joseph Pancoast, a pioneer in plastic surgery; and Baruch Blumberg, who won the Nobel Prize for the discovery of hepatitis B.

Dr. Tykocinski currently serves as Provost and Executive Vice President for Academic Affairs of Thomas Jefferson University, as well as The Anthony F. and Gertrude M. DePalma Dean of its Sidney Kimmel Medical College. He also served as president of Jefferson University Physicians for over five years. Before joining Jefferson in 2008, Dr. Tykocinski was professor and chair of the Department of Pathology and Laboratory Medicine at the University of Pennsylvania for a decade.

Dr. Tykocinski’s research contributions have been in the fields of molecular and cellular immunology, cell surface engineering, and biologics innovation. He has pioneered new categories of fusion protein pharmaceuticals, with applications to cancer and autoimmune diseases. Dr. Tykocinski serves as scientific advisory board chair for KAHR-Medical, the Israeli biotech company he founded in 2007 for fusion protein pharmaceuticals. Dr. Tykocinski’s scientific contributions also extend to the development of novel cell therapy strategies and the engineering of a novel class of mammalian gene expression vectors now distributed worldwide. He holds a series of research patents in the fields of molecular and cellular immunology, and is a fellow of the National Academy of Inventors.

Dr. Tykocinski is past president of the American Society for Investigative Pathology/Federation of American Societies for Experimental Biology (ASIP/FASEB) and the Association of Pathology Chairs. He has been on the editorial boards of the American Journal of Pathology, Molecular Oncology and Genetics Research, and was honored with the Warner-Lambert/Parke-Davis Award for Outstanding Research from ASIP/FASEB. He earned a B.A. in biology magna cum laude from Yale University and his M.D. from New York University.

Posted in University Headlines